WELCOME TO
FEATURING DR. YOUNGMEE JEE – AUGUST 30, 2021 – “COVID-19 RESEARCH IN INSTITUT PASTEUR KOREA”
Youngmee Jee, MD, PhD
CEO
Institut Pasteur Korea, South Korea
GVN Center Director
Bio sketch
Dr. Youngmee Jee (M.D., Ph.D) is Chief Executive Officer of the Institut Pasteur Korea and also serves as Special Representative for Health Diplomacy, Korea Foundation. Dr. Jee has broad experience in collaborating with WHO and international public health partners. Currently, Dr. Jee is a member of the WHO International Health Regulation Emergency Committee on COVID-19 and of the WHO Scientific Advisory Group for the Blueprint on Research and Development Preparedness for Epidemics. Dr. Jee also served as a member of Strategic Advisory Group of Experts for Immunization (SAGE) during 2017-2020.
From 2014 to 2019, Dr. Jee served as Director-General of the Center for Infectious Disease Research of the KCDC and led international activities including the WHO-Korea Joint Mission on MERS Outbreak in 2015 and the WHO International Health Regulations (IHR) Joint External Evaluation (JEE) in 2017. She also served as a member of the Board of Trustees of the International Vaccine Institute (2016-2019) and President of the Korean Society of Infectious Diseases (2018-2019). Dr. Jee received a President Medal of Distinguished Service in 2017.
Dr. Jee worked as Regional Laboratory Coordinator in the Expanded Programme on Immunization of the WHO Western Pacific Regional Office (WPRO) during 2007-2014 to coordinate national and regional public health institutes in over 20 countries in the region. Dr. Jee received her M.D. from the College of Medicine, Seoul National University, a Diploma in Medical Microbiology from the London School of Hygiene Tropical Medicine, and her Ph.D. from the University of London.